Endpoints News 生物医药· Nicole DeFeudis·· 3 天前AI 评分40
AstraZeneca 和 Alexion 的 MG 治疗药物 Klygefa 获 FDA 批准
AstraZeneca, Alexion's myasthenia gravis treatment enters crowded market
AI 导读
AstraZeneca 和 Alexion 的 MG 治疗药物 Klygefa(通用名:gefurulimab)获 FDA 批准,作为首个用于治疗成人全身性肌无力症的自注射药物。
正文
AstraZeneca and Alexion won FDA approval Monday for their self-administered generalized myasthenia gravis (gMG) drug Klygefa.
The drug, also known as gefurulimab, is a once-weekly …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news